Innocan Pharma Corp
OTC:INNPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innocan Pharma Corp
OTC:INNPF
|
IL |
|
E
|
ESSA Industries Indonesia Tbk PT
SWB:71S
|
ID |
|
P
|
Pharol SGPS SA
ELI:PHR
|
PT |
|
P
|
Philip Morris CR as
PSE:TABAK
|
CZ |
|
Bakrie & Brothers Tbk PT
IDX:BNBR
|
ID |
|
M
|
Meta Platforms Inc
DUS:FB2A
|
US |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
B
|
Battalion Oil Corp
F:RAQB
|
US |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
Intrinsic Value
Is INNPF undervalued or overvalued?
See the intrinsic value estimate for Innocan Pharma Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
INNPF looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with INNPF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Innocan Pharma Does
Innocan Pharma Corp develops drug products based on cannabinoids, the active compounds from cannabis plants, with a focus on long-acting therapies for pain relief and other medical uses. The company is trying to turn cannabis-derived ingredients into regulated pharmaceutical products rather than consumer hemp or recreational items.
- Headquarters
- Israel IL
- Employees
- 8
- IPO date
- Sep 24, 2019
Earnings Waterfall
Innocan Pharma Corp
The intrinsic value for Innocan Pharma Corp (INNPF) under the Base Case is hidden USD.
Compared with the current market price of 1.4 USD, the stock appears hidden.